NCT05083338Completed
Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy
Prospective Evaluation of Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy in Adult Patients
Source: ClinicalTrials.gov · Last updated 13 Feb 2024
Brief summary (registry, in English)
This study learns if depression, anxiety, and catastrophizing (thought patterns that prompt people to expect the worst) are associated with chronic pain after surgery among patients who are scheduled to have cytoreductive surgery with intraoperative hyperthermic chemotherapy. Information from this study may improve the understanding of persistent and chronic postsurgical pain integrating multiple layers of biological and behavioral sciences.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 24 (actual)
- First submitted
- 7 Oct 2021
- Start date
- Aug 2021
- Primary completion date
- Feb 2024
- Lead sponsor
- M.D. Anderson Cancer Center
- NCT number
- NCT05083338
What you commit to
- Study type: Observational
- Participants enrolled: 24
- From Aug 2021 to the primary completion date, Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with extra-abdominal metastatic disease
Other
- ASA \>= 4 or emergency surgeries
- Patients cognitive or neurologically unable to complete questionnaires preoperatively
- Non-English-speaking patients
- Pregnant women
Who the study is looking for
- 18 years of age or older; with or without history of preoperative abdominal pain
- American Society of Anesthesiologists physical status (ASA) 1-4
- Scheduled surgery: open CRS-HIPEC surgery for primary peritoneal malignancy or secondary carcinomatosis (i.e., appendiceal, colorectal and gastric cancers)
- Written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| M D Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.